Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Mixing Time Validation – V 2.0

Posted on By

Elixir Department: SOP for Mixing Time Validation – V 2.0

Standard Operating Procedure for Mixing Time Validation in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/095/2025
Supersedes SOP/ELX/095/2022
Page No. Page 1 of 8
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a validated and scientifically justified procedure for determining and confirming the optimal mixing time required to achieve homogeneous elixir formulations during manufacturing.

2. Scope

This SOP applies to validation activities for establishing, reviewing, and revalidating mixing times for all elixir products in the Elixir Department during development, scale-up, or post-change control.

3. Responsibilities

  • Formulation Scientist / R&D:
    • Design mixing validation protocol based on product characteristics.
    • Determine sampling points and acceptance criteria.
  • Production Supervisor:
    • Ensure execution of validation batches as per protocol.
    • Record data during mixing trials and control parameters.
  • QA Officer:
    • Review and approve protocol and report.
    • Ensure compliance to validation master plan (VMP).
See also  Elixir Department: SOP for Cleaning Equipment in Explosion-Proof Areas - V 2.0

4. Accountability

The Head of Quality Assurance is accountable for ensuring that mixing time validation is performed according to regulatory guidelines, documented, and revalidated as needed.

5. Procedure

5.1

Preparation of Validation Protocol
  1. Prepare a protocol detailing:
    • Product name, batch size, equipment used
    • Mixing time intervals (e.g., 10, 20, 30, 40 minutes)
    • Sampling points (top, middle, bottom)
    • Parameters to test: pH, assay, viscosity, color, clarity
    • Acceptance criteria: RSD ≤ 5%, homogeneity within ±3%
  2. Obtain protocol approval from QA before execution.

5.2 Execution of Validation Batches

  1. Manufacture three consecutive batches as per approved manufacturing process.
  2. At each pre-defined time interval, collect samples from different depths.
  3. Analyze each sample in QC laboratory for defined parameters.
  4. Document observations in the Mixing Time Validation Log (Annexure-1).

5.3 Evaluation of Results

  1. Compare results for each time point to check when consistent homogeneity is achieved.
  2. Select the mixing time where all results meet acceptance criteria for all three batches.
  3. Ensure no further improvement in results is seen beyond that point.

5.4 Finalization and Documentation

  1. Summarize validation results and finalize optimal mixing time.
  2. Document final mixing time in the Master Formula Record (MFR).
  3. Attach protocol, results, and approval page in the Validation Summary Report.

5.5 Revalidation Criteria

  1. Change in batch size (±10% or more)
  2. Change in mixing equipment or tank geometry
  3. Product formulation change
  4. Failure in product homogeneity during routine batch

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • MFR: Master Formula Record
  • VMP: Validation Master Plan
  • RSD: Relative Standard Deviation

7. Documents

  1. Mixing Time Validation Log (Annexure-1)
  2. Mixing Time Validation Protocol and Report
  3. Master Formula Record (MFR)

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO TRS 1019 – GMP Validation Guidelines
  • 21 CFR Part 211.110 – Sampling and Testing of In-Process Materials

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Mixing Time Validation Log

Batch No. Time Interval (min) Top Middle Bottom RSD (%) Result
ELX-1034 20 98.2% 97.9% 98.1% 0.15 Pass
ELX-1034 30 98.0% 97.8% 97.9% 0.10 Pass

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Added revalidation triggers and RSD thresholds Process Standardization QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: BA-BE Studies: SOP for Data Integrity in Bioanalytical Labs – V 2.0
Next Post: Creams: SOP for Inline Labeling Inspections during Packing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version